Abstract |
AS-101 is a tellurium-based compound with known immunomodulating properties. The ability of AS-101 to potentiate the effects of chemotherapeutic drugs and augment cytokine production in vivo has led to clinical trials on AS-101 which are currently being carried out in cancer patients. In the present study we show that AS-101 selectively augments the release of TNF alpha and IL-1 alpha and inhibits the release of IL-10 by lipopolysaccharide (LPS)-stimulated mouse peritoneal macrophages and human monocytes. It does not significantly affect the release of IL-6 or leukemia inhibitory factor (LIF). By itself AS-101 does not induce the release of any of these cytokines. Analysis of IL-10 and TNF alpha RNA levels using semiquantitative PCR reveals that AS-101 blocks the transcription of IL-10 mRNA, but does not significantly affect TNF alpha mRNA. Although both AS-101 and interferon (IFN)-gamma inhibit IL-10, AS-101, unlike IFN-gamma, does not prime macrophages for LPS-induced nitric oxide release and does not appear to significantly affect monocyte HLA-DR expression. Our data suggest that AS-101 is a partial IFN-gamma agonist and may explain the shift toward the release of Th-1 type cytokines observed in AS-101-treated patients.
|
Authors | G Strassmann, T Kambayashi, C O Jacob, D Sredni |
Journal | Cellular immunology
(Cell Immunol)
Vol. 176
Issue 2
Pg. 180-5
(Mar 15 1997)
ISSN: 0008-8749 [Print] Netherlands |
PMID | 9073392
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Adjuvants, Immunologic
- Ethylenes
- HLA-DR Antigens
- Interleukin-1
- Lipopolysaccharides
- RNA, Messenger
- Tumor Necrosis Factor-alpha
- Interleukin-10
- ammonium trichloro(dioxoethylene-O,O'-)tellurate
- Interferon-gamma
|
Topics |
- Adjuvants, Immunologic
(pharmacology)
- Animals
- Cells, Cultured
- Ethylenes
(pharmacology)
- HLA-DR Antigens
(biosynthesis)
- Humans
- Interferon-gamma
(pharmacology)
- Interleukin-1
(metabolism)
- Interleukin-10
(antagonists & inhibitors, genetics, metabolism)
- Lipopolysaccharides
(pharmacology)
- Macrophages, Peritoneal
(drug effects, metabolism)
- Male
- Mice
- Mice, Inbred C57BL
- Monocytes
(drug effects, metabolism)
- RNA, Messenger
(biosynthesis)
- Tumor Necrosis Factor-alpha
(drug effects, genetics, metabolism)
|